Form 4 for TXG 10x Genomics, Inc.

Accepted 2023-03-23 00:00:00 ET · period of report 2023-03-21 · accession 0001140361-23-013504 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2023-03-23	2023-03-21	TXG	McAnear Justin J.	CFO	A - Grant	$0.00	+26.0K	101.5K	+34%	$0
DM	2023-03-23	2023-03-21	TXG	McAnear Justin J.	CFO	A - Grant	$0.00	+39.0K	26.0K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2023-03-21	A	A	25,991	$0.00	101,510	D	—	—	(F1) Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/16th of the RSUs shall vest on each quarterly anniversary measured from February 21, 2023, subject to the Reporting Person continuing as a service provider through each such date.
2	Derivative	Performance based Restricted Stock Units	2023-03-21	A	A	12,996	$0.00	12,996	D	— · — to 2028-04-01	12,996 Class A Common Stock	(F3) Each Performance-Based Restricted Stock Unit ("PSU") represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/3rd of the PSUs shall vest upon the Issuer's Class A Common Stock achieving each of three escalating stock price milestones, subject to the Reporting Person continuing as a service provider through each such date.
3	Derivative	Stock Option (right to buy)	2023-03-21	A	A	25,991	$0.00	25,991	D	$50.10 · — to 2033-03-21	25,991 Class A Common Stock	(F2) 1/48th of the total number of shares subject to the option vest on each monthly anniversary measured from April 1, 2023, subject to the Reporting Person continuing as a service provider through each such date.